Gottlieb Is Nominee for FDA Commissioner
President Donald Trump announced (here) that he plans to nominate Scott Gottlieb to serve as Food and Drug Administration (FDA) commissioner. Gottlieb is a physician, a resident fellow at the American Enterprise Institute, a venture partner at venture capital firm…
Sign up for a free preview to unlock the rest of this article
Export Compliance Daily combines U.S. export control news, foreign border import regulation and policy developments into a single daily information service that reliably informs its trade professional readers about important current issues affecting their operations.
New Enterprise Associates, and a clinical professor at New York University School of Medicine. Gottlieb was the FDA’s deputy commissioner for medical and scientific affairs from 2005 to 2007. The Senate Health, Education, Labor and Pensions Committee will consider Gottlieb’s nomination. Committee ranking member Patty Murray, D-Wash., in a statement (here) said she will closely evaluate Gottlieb on his approach to food safety, youth tobacco use prevention, and encouraging markets for generic and biosimilar drugs, among other things. Committee Chairman Lamar Alexander, R-Tenn., in a statement (here) lauded Gottlieb’s qualifications as a physician and former FDA official.